Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Return on Assets (2016 - 2025)

Aptevo Therapeutics (APVO) has disclosed Return on Assets for 10 consecutive years, with 0.95% as the latest value for Q3 2025.

  • Quarterly Return on Assets fell 97.0% to 0.95% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.95% through Sep 2025, down 97.0% year-over-year, with the annual reading at 0.04% for FY2023, 2.0% up from the prior year.
  • Return on Assets hit 0.95% in Q3 2025 for Aptevo Therapeutics, up from 1.06% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.05% in Q3 2023 to a low of 1.06% in Q2 2025.
  • Historically, Return on Assets has averaged 0.12% across 5 years, with a median of 0.02% in 2021.
  • Biggest five-year swings in Return on Assets: grew 4bps in 2023 and later tumbled -108bps in 2025.
  • Year by year, Return on Assets stood at 0.02% in 2021, then skyrocketed by 95bps to 0.03% in 2022, then surged by 55bps to 0.05% in 2023, then plummeted by -59bps to 0.02% in 2024, then crashed by -4992bps to 0.95% in 2025.
  • Business Quant data shows Return on Assets for APVO at 0.95% in Q3 2025, 1.06% in Q2 2025, and 0.54% in Q1 2025.